An innovative approach to protecting patients during breast and lung radiation therapy
Driving advances in cancer care
Regular surveillance necessary to identify safety signals
Potential treatment option for patients who are ineligible for cisplatin
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Blood-based assay could alleviate barriers to lung cancer screening
Transperineal ultrasound a viable, non-invasive option for monitoring intra-fractional prostate motion
State-of-the-art facility expands global care, professional opportunities
Radiomic nomogram helps clinicians assess risk in patients treated with stereotactic body radiation therapy
Insights from 15 years of experience of Cleveland Clinic’s spine tumor board
Pinpointing how tumors reprogram platelets and trigger blood clots
Advertisement
Advertisement